Key result
ANGPTL4 induces specific capillary morphogenesis with linear adherens junctions and counteracts VEGF-induced sprouting and cell migration by regulating VEGFR2 and ERK1-2 signaling.
Why the study?
While ANGPTL4 is known to regulate angiogenesis and vascular permeability, its context-dependent role related to VEGF in capillary morphogenesis remained to be deciphered.
In vitro 3D models demonstrate that ANGPTL4 induces specific capillary morphogenesis and restricts VEGF-induced sprouting by stabilizing endothelial adherens junctions.
ANGPTL4's VEGF-contextual effects in 3D capillaries merit targeted study; leaves open therapeutic translation pending in vivo validation.
Angiopoietin-like 4 (ANGPTL4) is a target of hypoxia that accumulates in the endothelial extracellular matrix. While ANGPTL4 is known to regulate angiogenesis and vascular permeability, its context-dependent role related to vascular endothelial growth factor (VEGF) has been suggested in capillary morphogenesis. We here thus develop in vitro 3D models coupled to imaging and morphometric analysis of capillaries to decipher ANGPTL4 functions either alone or in the presence of VEGF. ANGPTL4 induces the formation of barely branched and thin endothelial capillaries that display linear adherens junctions. However, ANGPTL4 counteracts VEGF-induced formation of abundant ramified capillaries presenting cell-cell junctions characterized by VE-cadherin containing reticular plaques and serrated structures. We further deciphered the early angiogenesis steps regulated by ANGPTL4. During the initial activation of endothelial cells, ANGPTL4 alone induces cell shape changes but limits the VEGF-induced cell elongation and unjamming. In the growing sprout, ANGPTL4 maintains cohesive VE-cadherin pattern and sustains moderate 3D cell migration but restricts VEGF-induced endothelium remodeling and cell migration. This effect is mediated by differential short- and long-term regulation of P-Y1175-VEGFR2 and ERK1-2 signaling by ANGPTL4. Our in vitro 3D models thus provide the first evidence that ANGPTL4 induces a specific capillary morphogenesis but also overcomes VEGF effect.
No takes yet. Share an insight, caveat, or question.
Liabotis et al. (2022) studied Angiogenesis and capillary morphogenesis. Angiopoietin-like 4 (ANGPTL4) vs. VEGF alone or control was evaluated on Capillary morphogenesis and endothelial adherens junction stabilization. ANGPTL4 induces specific capillary morphogenesis with linear adherens junctions and counteracts VEGF-induced sprouting and cell migration by regulating VEGFR2 and ERK1-2 signaling.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: